image

SEC Filings

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
Filing date Description Form View

Report of unscheduled material events or corporate event

8-K EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Report of unscheduled material events or corporate event

8-K EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Initial filing by director officer or owner of more than ten percent.

3 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

EFFECT

EFFECT View HTML

Data provided by Kaleidoscope.